Protocol Design Featured Articles

  1. BeiGene Moves Fast, Stays In-House To Conduct Its Cancer Clinical Trials 11/1/2024

    Mark Lanasa, MD, Ph.D. explains how BeiGene gets medicines to more patients, in part by an ability to realize strategic cost and time advantages of a unique (and fast) R&D approach and by bringing clinical operations in-house. 

  2. PI Talks Recruitment, Retention, & Trial Design For Multiple Myeloma Studies 10/28/2024

    Multiple myeloma specialist James Berenson, MD discusses trial selection, recruitment strategies, patient-centric trial design, and more.

  3. Clinical Trial Operations In Low- And Middle-Income Countries: 5 Keys To Success 10/24/2024

    Following these five key lessons when planning and implementing clinical trial operations in low- and middle-income countries will lead you to more successful outcomes.

  4. Panavance Details IND Prep Ahead Of FDA Submission For Ovarian Cancer Trial 10/23/2024

    Panavance CEO Greg Bosch discusses the company’s pursuit of a second trial for misetionamide, walking us through IND preparations, CRO selection, and securing funding. 

  5. 3 Practical Solutions For Easing Site Burdens 10/22/2024

    Clinical research expert and breast cancer survivor Rosalie Filling shares three straightforward ways sponsor companies can help support clinical research sites.

  6. Overcoming Trial Barriers By Looking Through The Lens Of Product Adoption 10/17/2024

    In the final article of this series, Liam and Kim Eves explore how various drug candidates come inherent with barriers to adoption that directly impact how participants and providers engage with clinical research. 

  7. Understanding How Strategies For Product Adoption Can Inform Clinical Trial Delivery 10/16/2024

    In part two of this series, Liam and Kim Eves discuss product archetypes and adoption drivers as they relate to commercial endeavors and looks closely at how they can be applied to clinical trial execution.

  8. What Can Clinical Researchers Learn From Commercial Product Launches? 10/15/2024

    Part one of this three-part series exploring modern drug development and its impact on clinical trials and new drug launches connects product adoption concepts with much earlier clinical trial activities.

  9. How One Biotech Is Using FDA 505(b)(2) To Get Drugs To Patients Quicker And Cheaper 10/9/2024

    Terran Biosciences CEO Sam Clark, MD, Ph.D. explains how his team is leveraging the 505(b)(2) regulatory pathway to get its new schizophrenia drug to patients quickly and affordably. 

  10. Want To Improve Study Startup? Get More Efficient 10/3/2024

    John McAdory, VP of ClinOPs at CG Oncology, recognizes that today’s clinical trial designs tend to be very complex, which complicates study startup. He says the key to improving this challenge is to find small ways to be more efficient throughout the process.